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A commentary on
Early liver transplantation for severe alco-
holic hepatitis
by Mathurin, P., Moreno, C., Samuel, D., 
Dumortier, J., Salleron, J., Durand, F., Castel, 
H., Duhamel, A., Pageaux, G. P., Leroy, V., 
Dharancy, S., Louvet, A., Boleslawski, E., 
Lucidi, V., Gustot, T., Francoz, C., Letoublon, 
C., Castaing, D., Belghiti, J., Donckier, V., 
Pruvot, F. R., and Duclos-Vallée, J. C. (2011). 
N. Engl. J. Med. 365, 1790–1800.
A recent French trial in the New England 
Journal of Medicine (Mathurin et al., 
2011) reported that early orthotopic liver 
transplantation (OLTx) improves survival 
in patients with a first episode of severe 
alcoholic hepatitis (AH) not responding 
to medical therapy. In this trial, 26 patients 
with severe AH at high risk of death were 
selected (i.e., <2% of patients admitted for 
an episode of severe AH). The results of this 
trial are very encouraging as the cumulative 
6-month survival rate was higher among 
patients who received early transplantation 
than among those who did not (P < 0.001). 
Notably, this benefit of early transplantation 
was maintained through 2 years of follow-
up (P = 0.004).
Alcoholism is still considered by many 
individuals and clinicians, as a bad habit 
and there is a general reluctance to trans-
plant alcoholic individuals who still drink. 
However, research in neuroscience has 
improved dramatically in the last decades, 
and we do know by now that alcoholism is 
a chronic relapsing medical disease of the 
brain, and not a bad behavior. Let’s make a 
comparison with hepatitis C virus (HCV). 
We all know that given the presence of 
extrahepatic sites of HCV replication, the 
new transplant liver is infected by HCV in 
virtually all patients, with a 10- to 20-fold 
increase in levels of viremia after liver trans-
plantation, and progression to HCV-related 
cirrhosis is estimated to reach 20–30% at 
5-year follow-up (Gruener et al., 2004). No 
one, however, would deny an OLTx to an 
HCV-infected patient because of the “risk” 
of the re-infection after surgery.
As for alcoholic patients, at present, a 
minimum of 6 months of total alcohol absti-
nence before OLTx is required to reduce the 
risk of alcohol recidivism. Notably, in the 
French trial (Mathurin et al., 2011) not only 
survival rate was higher in patients receiv-
ing early OLTx, but also a very low number 
of patents (n = 3; 11.5%) relapsed, i.e., one 
at 720 days, one at 740 days, and one at 
1140 days after transplantation (Mathurin 
et al., 2011). The take home message of this 
trial is very important and has significant 
clinical implications. This trial, in fact, 
clearly suggests the need to re-consider 
the 6-month rule. Alcoholic patients who 
receive OLTx might have a better survival 
rate if the transplant is performed sooner. 
As such, it is important, at least in selected 
cases, to consider the possibility to perform 
the OLTx the soonest possible in alcoholic 
patients with severe AH. The possibility 
to re-consider the 6-month rule, however, 
needs to be discussed by the scientific and 
clinical community, together with the need 
to provide more effective monitoring and 
treatments for alcoholism both before and 
after the OLTx. As such, there is a crucial 
need to develop a more integrated approach 
in the management of these patients, includ-
ing the need to follow-up these patients by 
team players coming from different fields 
(e.g., hepatology, psychiatry, addiction 
medicine, surgery).
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